Related Experiment Video
Updated: Nov 7, 2025

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD
Vincenzo Russo1, Pia Clara Pafundi2, Alfredo Caturano2
1Department of Medical Translational Sciences, Division of Cardiology, Monaldi Hospital, University of Campania "Luigi Vanvitelli," Naples, Italy.
Insights
Drug-induced Brugada syndrome (BrS) patients have a low risk of cardiac events. Electrophysiological study (EPS) and syncope help guide implantable cardioverter-defibrillator (ICD) decisions but do not reliably predict risk.
Area of Science:
- Cardiology
- Electrophysiology
- Genetics
Background:
- Brugada syndrome (BrS) is an inherited cardiac condition associated with sudden cardiac death.
- Limited real-world data exist on long-term outcomes for drug-induced type 1 BrS.
- Risk stratification for these patients remains an area of ongoing investigation.
Purpose of the Study:
- To retrospectively evaluate long-term outcomes in patients with drug-induced type 1 BrS.
- To assess the prognostic value of electrophysiological study (EPS) in stratifying risk for these patients.
- To identify predictors for implantable cardioverter-defibrillator (ICD) implantation and arrhythmia induction during EPS.
Main Methods:
- The Italian Brugada Syndrome (IBRYD) study enrolled 226 patients with drug-induced type 1 BrS from 9 centers.
- The primary endpoint was a composite of appropriate ICD therapy and sudden cardiac death.
- Analysis included clinical predictors, EPS findings, and their association with outcomes.
Main Results:
- 142 patients (62.8%) received an ICD, primarily due to syncope or inducible ventricular tachyarrhythmias during EPS.
- Over a median follow-up of 106 months, 11 patients (4.9%) experienced primary outcome events, with a low annual ICD therapy incidence.
- Ventricular tachyarrhythmia inducibility during EPS showed low positive predictive value but high negative predictive value for arrhythmic events. ICD-related complications and inappropriate shocks occurred in 4.9% of patients.
Conclusions:
- Drug-induced type 1 BrS is associated with a very low arrhythmic risk.
- Syncope and EPS positivity inform ICD implantation decisions but do not effectively stratify high-risk patients.
- A balanced consideration of arrhythmic risk and ICD-related complications is crucial for optimizing patient management.
Objectives:
This study aimed to retrospectively assess long-term outcome and the prognostic role of electrophysiological study (EPS) for risk stratification of drug-induced type 1 Brugada syndrome (BrS) patients.
Background:
BrS is a hereditary cardiac disease, predisposing to sudden cardiac death. Few real-world data are available on long-term outcomes of drug-induced type 1 BrS patients, and questions about risk stratification still remain unanswered.
Methods:
The IBRYD (Italian Brugada Syndrome) study is a multicenter observational retrospective study. A total of 226 drug-induced type 1 BrS patients were enrolled from 9 Italian tertiary referral institutions. Primary endpoint was a composite of appropriate implantable cardioverter-defibrillator (ICD) therapy and sudden cardiac death. The authors further assessed clinical predictors to ICD implantation, as well as for arrhythmia induction at EPS, along with EPS as potential risk factor for the outcomes of interest.
Results:
142 patients (62.8%) received an ICD due to syncope and/or inducible ventricular tachyarrhythmias at EPS. During a median follow-up of 106 months, 11 patients (4.9%) experienced primary outcome events. The ICD therapy median annual incidence over 8 years was 0.38% (interquartile range: 0% to 1.47%). Ventricular tachyarrhythmia inducibility during EPS was not predictive of arrhythmic events in ICD recipients versus non-ICD patients and in symptomatic versus asymptomatic subgroups, showing a low positive predictive value (9.6% and 8.9%, respectively) versus a high negative predictive value (96.6% and 95%, respectively). The authors reported 29 ICD-related complications and 4.9% inappropriate shocks.
Conclusions:
Drug-induced type 1 BrS patients have a very low arrhythmic risk. Clinical decision for implantation is supported by syncope and/or EPS positivity, though they fail to stratify high-risk patients. A better risk-to-benefit ratio should be pursued, considering both arrhythmic risk and ICD-related complications.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Dysrhythmias V: Evaluating Dysrhythmias
Aneurysm II: Clinical Manifestations and Diagnostic Studies
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Electrophysiology of Normal Cardiac Rhythm

